A prospective study of comprehensive genomic testing to identify actionable variants in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).

被引：0
|
作者：
Shevrin, Daniel [1 ]
Yang, Mathew [2 ]
Sabatini, Linda [2 ]
Pfanzelter, Nicklas [2 ]
Akroush, Michael [2 ]
Alnajar, Hussein [2 ]
Helseth, Larry [2 ]
机构：
[1] NorthShore Univ Hlth Syst, Evanston Hosp, Kellogg Canc Ctr, Evanston, IL USA
[2] NorthShore Univ Hlth Syst, Evanston, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
3282-206-4760-6705; 283-2494-5577-2829-12292; 3282-206-3691-2722; 3282-206-3666-7655; 3282-270-151-11105; 298-4767-5870; 283-2494; 11; 6; 3; 2; 242; 1; 38092-29068; 38092-20446; 38092-20212; 38092-18438;
D O I：
10.1200/JCO.2024.42.4_suppl.185
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：185 / 185
页数：1
相关论文
共 50 条
  • [1] Real-world patterns of genomic testing in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC)
    Shore, N.
    Ionescu-Ittu, R.
    Yang, L.
    Laliberte, F.
    Payne, S.
    Gayle, A.
    Amin, S.
    Mahendran, M.
    Lejeune, D.
    Yu, L.
    Burgents, J.
    Duh, M. S.
    Ghate, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S526 - S527
  • [2] Treatment sequence in elderly metastatic castration-resistant prostate cancer (mCRPC) patients (pts) in a prospective cohort study.
    Jose Mendez-Vidal, Maria
    Lozano, Rebeca
    Castro, Elena
    Romero-Laorden, Nuria
    Rodriguez-Vida, Alejo
    Lainez, Nuria
    Hernandez, Amaia
    Villatoro, Rosa
    Zambrana, Francisco
    Villa Guzman, Jose Carlos
    Garcia Dominguez, Rocio
    Galvan Ruiz, Saray
    Escribano, Ricardo
    Gallardo Diaz, Enrique
    Querol, Rosa
    Luque, Raquel
    Gonzalez del Alba, Aranzazu
    Puente, Javier
    Olmos, David
    Lorente, David
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] A phase 1 study of AMG 509 in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
    Danila, Daniel Costin
    Waterhouse, David Michael
    Appleman, Leonard Joseph
    Pook, David William
    Matsubara, Nobuaki
    Dorff, Tanya B.
    Lee, Jae-Lyun
    Armstrong, Andrew J.
    Kim, Miso
    Horvath, Lisa
    Sumey, Christopher Joseph
    Cooner, Freda
    Salvati, Mark
    Stieglmaier, Julia
    Kelly, William Kevin
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] Phase II Study with metastatic castration-resistant Prostate Cancer (mCRPC) Patients
    Rexer, H.
    Graefen, M.
    UROLOGE, 2017, 56 (11): : 1468 - 1470
  • [5] Avelumab in metastatic castration-resistant prostate cancer (mCRPC).
    Fakhrejahani, Farhad
    Madan, Ravi Amrit
    Dahut, William L.
    Bilusic, Marijo
    Karzai, Fatima
    Cordes, Lisa M.
    Strauss, Julius
    Schlom, Jeffrey
    Gulley, James L.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] Avelumab in metastatic castration-resistant prostate cancer (mCRPC).
    Fakhrejahani, Farhad
    Madan, Ravi Amrit
    Dahut, William L.
    Karzai, Fatima
    Cordes, Lisa M.
    Schlom, Jeffrey
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [7] Characterizing longitudinal molecular changes in ctDNA in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
    Tran, Eli
    Jani, Chinmay
    Zhang, Nicole
    Tsai, Jill
    Pan, Elizabeth
    Panian, Justine
    McKay, Rana R.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 205 - 205
  • [8] Treatment (Rx) patterns and attrition rates in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
    Gebrael, Georges
    Jo, Yeonjung
    Hage Chehade, Chadi
    Ozay, Zeynep Irem
    Sayegh, Nicolas
    Ostrowski, Micah
    Campbell, Patrick
    Anderson, Ethan
    Nordblad, Blake
    Galarza Fortuna, Gliceida M.
    Mathew Thomas, Vinay
    Riaz, Irbaz Bin
    Graf, Ryon P.
    Guha, Avirup
    Maughan, Benjamin L.
    Roy, Soumyajit
    Antonarakis, Emmanuel S.
    Agarwal, Neeraj
    Swami, Umang
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [9] Cabazitaxel for octogenarian patients with metastatic castration-resistant prostate cancer (MCRPC)
    Tralongo, P.
    Bordonaro, S.
    Di Lorenzo, G.
    Borsellino, N.
    Facchini, G.
    Rossetti, S.
    Martelli, V.
    Longo, V.
    Tralongo, A. C.
    Caspani, F.
    Tuzi, A.
    Spada, M.
    Calvani, N.
    Carlini, P.
    De Giorgi, U. F. F.
    ANNALS OF ONCOLOGY, 2019, 30
  • [10] Dexamethasone in pretreated men with metastatic castration-resistant prostate cancer (mCRPC): A prospective study.
    Baciarello, Giulia
    Hamilou, Zineb
    Chebib, Ralph
    Albiges, Laurence
    Fuerea, Alina
    Loriot, Yohann
    Massard, Christophe
    Colomba, Emeline
    Di Palma, Mario
    Escudier, Bernard
    Fizazi, Karim
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
12345